October 28, 2021 Comments Off on New patent for Janssen Biotech drug ERLEADA Posted in: Patent Added Annual Drug Patent Expirations for ERLEADA Erleada is a drug marketed by Janssen Biotech and is included in one NDA. It is available from one supplier. There are nine patents…
The post New patent for Janssen Biotech drug ERLEADA appeared first on DrugP…
October 27, 2021 Comments Off on New patent for Rhythm drug IMCIVREE Posted in: Patent Added Annual Drug Patent Expirations for IMCIVREE Imcivree is a drug marketed by Rhythm and is included in one NDA. There are two patents protecting this drug. This drug has forty-three…
The post New patent for Rhythm drug IMCIVREE appeared first on DrugPate…